Next Big Future | Tissue engineering, replacement organs and regenerative medicine are getting friendlier regulations Next Big Future The FDA intends to promote the “least burdensome” rules for companies big and small that are seeking to develop new therapies, “while ensuring patient safety.” “Our policy will allow product manufacturers that time to engage with the FDA to determine ... |